Business & Deals
BioNTech Pays $205 Million to Jump the FDA Queue
BioNTech agreed to pay Scholar Rock $205 million for an FDA priority review voucher that cuts the review clock from ten months to six, as the market for the fast-pass tickets reprices toward a 2029 issuance sunset.
- Crédit Agricole Pitches a 45% Stake in Italy's Next Big Bank
- Mitsui Chemicals Is Buying Twice Its Size to Lead Chip Materials
- Who's Actually In Charge After the ARRAY-Shoals Merger?
- Marvell to Buy Lumentum for $115 Billion in Stock
- Guidewire Pays $1.7 Billion to Bring AI Into Insurance Pricing
- Schneider Electric Dilutes Shareholders €6 Billion to Fund the PTC Takeover
- LSEG’s $3.5 Billion Octus Deal Puts Private-Credit Data at the Center of Its Growth Plan
- Netflix’s Ad Shortfall Turns Surging Margins Into a Growth Test















































